Seminars in Oncology
Volume 31, Issue 5 , Pages 595-604, October 2004

Altered molecular pathways in gliomas: An overview of clinically relevant issues

  • Ravi D. Rao

      Affiliations

    • Department of Oncology, Division of Medical Oncology, Mayo Clinic and Foundation, Rochester, MN, USA.
    • ,
  • C. David James

      Affiliations

    • Division of Experimental Pathology, Mayo Clinic and Foundation, Rochester, MN, USA.
    • Corresponding Author InformationAddress reprint requests to C. David James, PhD, Division of Experimental Pathology, Mayo Clinic and Foundation, 200 First St SW, Rochester, MN 55905.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by the American Brain Tumor Association (ABTA)/Joel A. Gingras, Jr Fellowship.

PII: S0093-7754(04)00324-0

doi:10.1053/j.seminoncol.2004.07.002

Seminars in Oncology
Volume 31, Issue 5 , Pages 595-604, October 2004

Article Tools

* Image Usage & Resolution